Graftys is a company headquartered in France. Brouky records 1 investor associated with the company.
Develops, produces and commercialises synthetic bone graft substitutes based on calcium phosphate materials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.